References
1
Akcakaya A, Destek S. Surgical treatment of gastric cancer. Türk HM, editör. Mide Kanserleri. 1. Baskı. Ankara: Türkiye Klinikleri; 2019. p.33-41.(Turkish)
2
Fukagawa T. Role of staging laparoscopy for gastric cancer patients. Ann Gastroenterol Surg 2019;3:496–505. https://doi.org/10.1002/ags3.12283
3
Shandall A, Johnson C. Laparoscopy or scanning in oesophageal and gastric carcinoma? Br J Surg. 1985;72(6):449–51.
4
Burbidge S, Mahadya K, Naik K. The role of CT and staging laparos‐ copy in the staging of gastric cancer. Clin Radiol. 2013;68:251–5.
5
Ikoma N, Blum M, Chiang YJ, Estrella JS, Roy‐Chowdhuri S, Fournier K, et al. Yield of staging laparoscopy and lavage cytology for radiologically occult peritoneal carcinomatosis of gastric cancer. Ann Surg Oncol. 2016;23:4332–7.
6
Simon M, Mal F, Perniceni T, et al. Accuracy of staging laparoscopy in detecting peritoneal dissemination in patients with gastroe sophageal adenocarcinoma. Dis Esophagus. 2016;29:236.
7
Ajani JA, D’Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, et al. Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016 Oct;14(10):1286-1312. doi: 10.6004/jnccn.2016.0137. PMID: 27697982.
8
Sarela AI, Lefkowitz R, Brennan MF, Karpeh MS. Selection of patients with gastric adenocarcinoma for laparoscopic staging. Am J Surg2006;191:134–138.
9
Stell DA, Carter CR, Stewart I, Anderson JR. Prospective comparison of laparoscopy, ultrasonography and computed tomography in the staging of gastric cancer. Br J Surg 1996; 83:1260–2
10
Smyth E, Schoder H, Strong VE, Capanu M, Kelsen DP, Coit DG, et al. A prospective eval uation of the utility of 2-deoxy-2-[(18) F]fluoro D-glucose positron emission tomography and computed tomography in staging locally ad vanced gastric cancer. Cancer. 2012;118(22):5481-8
11
Fujitani K, Yang HK, Mizusawa J, Kim YW, Terashima M, Han SU, et al. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non‐curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet Oncol. 2016;17:309–18.
12
Tokunaga M, Mizusawa J, Machida N, Fukagawa T, Katai H, Nishida Y, et al. Phase II trial to evaluate the efficacy of neoadjuvant che‐ motherapy with S‐1 plus oxaliplatin followed by D2 gastrectomy with adjuvant S‐1 in locally advanced gastric cancer: Japan Clinical Oncology Group Study JCOG1509 (NAGISA trial). J Clin Oncol. 2017;35. Available at: https://ascopubs.org/doi/abs/10.1200/ JCO.2017.35.15_supple.TPS4134. Accessed February 05, 2019.
13
Thiels CA, Ikoma N, Fournier K, Das P, Blum M, Estrella JS, et al. Repeat staging laparoscopy for gastric cancer after preoperative therapy. J Surg Oncol. 2018;118:61–7.
